VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 115 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $33,680,000 | -42.3% | 1,965,000 | -27.6% | 0.57% | -45.5% |
| Q2 2021 | $58,378,000 | +2.4% | 2,714,000 | -28.5% | 1.04% | -20.2% |
| Q1 2021 | $57,016,000 | -19.6% | 3,796,000 | -29.7% | 1.31% | -45.8% |
| Q4 2020 | $70,946,000 | +34.8% | 5,399,277 | -0.9% | 2.41% | +26.3% |
| Q3 2020 | $52,647,000 | -4.1% | 5,450,000 | +13.5% | 1.91% | -20.7% |
| Q2 2020 | $54,912,000 | +16.0% | 4,800,000 | +5.1% | 2.41% | -17.7% |
| Q1 2020 | $47,324,000 | +2.0% | 4,568,000 | +61.5% | 2.93% | +9.3% |
| Q4 2019 | $46,407,000 | -1.5% | 2,828,000 | -20.3% | 2.68% | -14.3% |
| Q3 2019 | $47,117,000 | +5.9% | 3,548,000 | +12.3% | 3.12% | +11.3% |
| Q2 2019 | $44,496,000 | +115.4% | 3,158,000 | +250.9% | 2.80% | +126.2% |
| Q3 2018 | $20,655,000 | -51.2% | 900,000 | -59.5% | 1.24% | -55.2% |
| Q2 2018 | $42,367,000 | -3.3% | 2,224,000 | -14.5% | 2.77% | -17.4% |
| Q1 2018 | $43,810,000 | +7.6% | 2,600,000 | -2.9% | 3.35% | -17.5% |
| Q4 2017 | $40,706,000 | +48.4% | 2,678,000 | +74.8% | 4.06% | +25.7% |
| Q3 2017 | $27,423,000 | -18.5% | 1,532,000 | -25.8% | 3.23% | -24.7% |
| Q2 2017 | $33,643,000 | +49.4% | 2,064,000 | +28.4% | 4.29% | -7.8% |
| Q1 2017 | $22,512,000 | +143.3% | 1,608,000 | +177.2% | 4.65% | +112.5% |
| Q4 2016 | $9,251,000 | +1.1% | 580,000 | +5.5% | 2.19% | -25.5% |
| Q3 2016 | $9,152,000 | +2.2% | 550,000 | -31.2% | 2.94% | -13.8% |
| Q2 2016 | $8,952,000 | -33.1% | 800,000 | -50.0% | 3.41% | -35.1% |
| Q1 2016 | $13,376,000 | -11.9% | 1,600,000 | -1.8% | 5.25% | -3.0% |
| Q4 2015 | $15,175,000 | +77.0% | 1,630,000 | +114.5% | 5.42% | +84.9% |
| Q3 2015 | $8,573,000 | -40.8% | 760,000 | -33.5% | 2.93% | -43.7% |
| Q2 2015 | $14,492,000 | -31.8% | 1,142,000 | -50.0% | 5.20% | -44.7% |
| Q1 2015 | $21,241,000 | +103.8% | 2,284,000 | +213.7% | 9.41% | +87.9% |
| Q4 2014 | $10,425,000 | – | 728,000 | – | 5.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |